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2Abstract
Otoliths and the homologous otoconia in the inner ear are essential for balance. Their
morphogenesis is less understood than that of other biominerals, such as bone, and only a small
number of their constituent proteins have been characterized. As a novel approach to identify
unknown otolith proteins, we employed shotgun proteomics to analyze crude extracts from trout
and catfish otoliths. We found three proteins that had not been associated previously with otolith
or otoconia formation: ‘Secreted acidic cysteine rich glycoprotein’ (Sparc), an important bone
protein that binds collagen and Ca2+; precerebellin-like protein, which contains a C1q domain
and may associate with the collagenous otolin-1 during its assembly into a framework; and
neuroserpin, a serine protease inhibitor that may regulate local protease activity during
framework assembly. We then used the zebrafish to investigate whether Sparc plays a role in
otolith morphogenesis. Immunodetection demonstrated that Sparc is a true constituent of
otoliths. Knockdown of Sparc expression in morphant zebrafish resulted in four principal types
of defective otoliths: smaller, extra and ectopic, missing and fused, or completely absent. Smaller
size was the predominant phenotype and independent of the severity of otic-vesicle defects.
These results suggested that Sparc is directly required for normal otolith growth.
Keywords: inner ear, morphogenesis, biomineral, proteomics, immunofluorescence, antisense
oligonucleotides
3Introduction
Otoliths (“ear stones”) and the homologous otoconia (“ear dust”) are essential to the sense of
balance; they convey linear accelerations, including gravity, to sensory hair cells in the inner ear
(Hudspeth 1989). Their loss or dislocation causes various forms of disequilibrium, including
benign paroxysmal positional vertigo, the most common balance disorder in humans (Brandt
2001). The ear of actinopterygii (ray-finned fishes) contains only three large otoliths–the lapillus
in the utricle, the sagitta in the saccule, and the asteriscus in the lagena–each with a distinctive
and species-specific shape (Nolf 1985). In contrast, the vestibular organs of sarcopterygii (lobe-
finned fishes or higher vertebrates) hold innumerable small and barrel-shaped otoconia.
Otoconial growth is completed during early postnatal stages, whereas otoliths continue to grow
throughout life under the influence of circadian and seasonal rhythms; the resulting growth rings
form a stable record of a fish’s life history (Campana and Thorrold 2001).
Despite their intriguing shapes and physiological importance, little is known about the
formation of otoliths and otoconia (Söllner and Nicolson 2004; Hughes et al. 2006). Unlike bone,
they consist of microcrystalline calcium carbonate, rather than phosphate, and are completely
acellular. The key regulators of their morphogenesis are therefore thought to be the constituent
proteins, which account for less than 5% of their weight. In analogy to other biominerals (Weiner
and Addadi 1997), large and insoluble “framework” proteins may form a matrix that determines
the site of morphogenesis, whereas small and highly charged “control” proteins may direct the
deposition of Ca2+ and CO32– ions and thus determine the otolith’s or otoconium’s shape.
Many proteins in otoliths and otoconia remain unknown (Lundberg et al. 2006). Each
complement amounts to up to two dozen different proteins, as determined by gel electrophoresis
(Pote et al. 1993; Wang et al. 1998 ; Verpy et al. 1999; Murayama et al. 2000; Murayama et al.
42002; this manuscript). Only five proteins have been located in otoliths or otoconia as well as
functionally characterized. First, otoconin 90, the major otoconia protein, in mouse (Wang et al.
1998; Verpy et al. 1999; Zhao et al. 2007) and zebrafish (Petko et al. 2008), and its homolog
otoconin 22 in frog (Pote et al. 1993; Yaoi et al. 2004). Second, otolith matrix protein-1, the
major otolith protein, in trout and zebrafish (Murayama et al. 2000; Murayama et al. 2004;
Murayama et al. 2005). Third, otolin-1, a collagenous protein, in salmon and zebrafish
(Murayama et al. 2002; Murayama et al. 2004; Murayama et al. 2005) and in mouse (Zhao et al.
2007). Fourth, starmaker, a member of the secretory calcium-binding phosphoprotein family, in
zebrafish (Söllner et al. 2003) and otolith matrix macromolecule-64, its likely ortholog, in trout
(Tohse et al. 2008). Fifth, secreted phosphoprotein 1 or osteopontin, a secretory calcium-binding
phosphoprotein prominent in bone and dentin, in mouse (Sakagami 2000; Thalmann et al. 2006;
Zhao et al. 2008). Another half dozen proteins, including calbindin D-28K (Piscopo et al. 2003;
Piscopo et al. 2004), SPARC-like 1, countertrypin, and fetuin-A (Thalmann et al. 2006; Zhao et
al. 2007), have been only located in otoconia, but not yet characterized.
To identify and characterize novel otolith proteins, we have combined the use of trout
and catfish as rich sources for proteomics and of zebrafish as a tractable model for functional
studies. Here, we report ‘secreted acidic cysteine rich glycoprotein’ (Sparc; also known as
osteonectin or BM-40), precerebellin-like protein (Cblnl), and neuroserpin (SerpinI1) as
constituent otolith proteins. Furthermore, we demonstrate that Sparc, a major bone protein, is
required for normal otolith growth. All three proteins may interact with otolin-1 during the
assembly of the otolith framework and mineralization.
5Materials and methods
Animal husbandry
All experiments were conducted in accordance with a protocol approved by the University of
Illinois Institutional Animal Care and Use Committee. Zebrafish (Scientific Hatcheries,
Huntington Beach, CA) were maintained live under standard conditions (Westerfield 2000) and
staged according to Kimmel and colleagues (1995).
Otoliths
Adult fish heads were from the following sources: white sturgeon, Stolt Sea Farm, Elverta, CA;
bighead carp, Big River Fish Corp., Pearl, IL; channel catfish, USDA ARS Catfish Genetics
Research Unit, Stoneville, MS, and Illinois Fish Farmers Cooperative, Pinckneyville, IL; black
ghost, Dr. Mark Nelson, University of Illinois, Urbana, IL; rainbow trout, Idaho Trout Co., Buhl,
ID or Schnucks, Urbana, IL; and tilapia, Tony’s Finer Foods, Chicago, IL. Dissected otoliths
were cleaned with fine forceps, bleached briefly with 0.65% wt/vol sodium hypochlorite (Secor
et al. 1991), sonicated in deionized water (conductivity > 18 MΩ/cm), and rinsed with a dental
water jet. Trout otoliths for mass spectrometry were not bleached.
Isolation and electrophoresis of otolith proteins
Otoliths were dissolved with a two-fold excess of EDTA in the presence of protease inhibitors
(cOmplete; Roche Diagnostics, Indianapolis, IN), and insolubles were pelleted by centrifugation
at 16,100 × g for 15 min at 4°C. The buffer of the soluble fraction was exchanged for a
denaturing solution containing 7 M urea, 2% wt/vol 3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate hydrate (CHAPS), 0.5% wt/vol Zoom carrier ampholytes 3-10 (Invitrogen,
6Carlsbad, CA), protease inhibitors, 8 mM Tris, and 7.5 mM HCl (final pH 7.0-7.2) by
ultracentrifugation with a nominal cut-off of 10 kDa; the insoluble pellet was taken up in the
same solution. After alkylation with iodoacetamide, 4x NuPAGE LDS sample buffer
(Invitrogen) and dithiothreitol were added to final concentrations of 1x and 48 mM, respectively,
and the samples were electrophoresed through precast NuPAGE Bis-Tris 4-12% polyacrylamide
gels in a 2-(N-Morpholino) ethanesulfonic acid (MES) running buffer containing sodium
dodecylsulfate and NuPAGE antioxidant (Invitrogen).  The separated proteins were visualized
with a SilverQuest staining kit (Invitrogen).
Mass spectrometry
Otoliths were dissolved as above, with the addition of 2.5 mM Tris(2-carboxyethyl) phosphine
hydrochloride. Soluble protein was precipitated (UPPA concentration kit; Genotech, St. Louis,
MO) and quantitated in a membrane-based fluorescence assay (EZQ kit; Molecular Probes,
Eugene, OR). After alkylation with iodoacetamide, the protein was digested with proteomics-
grade trypsin (Genotech) at 55°C for 15 min in a microwave incubator (Discover Digestor;
CEM, Matthews, NC).
The tryptic peptides were separated by reverse-phase high-pressure liquid
chromatography on an Atlantis dC18 NanoEase column (3 µm particle size, 75 µm x 150 mm;
Waters, Milford, MA) with a 60-min gradient of 0%-50% vol/vol acetonitrile containing 0.1%
vol/vol formic acid at a flow rate of 250 nl/min and analyzed on-line with a Waters Q-ToF
API-US tandem mass spectrometer (Protein Sciences Facility, Biotechnology Ctr., Univ. of
Illinois).
A custom database of chordate proteins was compiled from all sequences that were
available from the National Center for Biotechnology Information as of 12/5/2006, including
7GenBank (release 156), or that were associated with fish genomes in Ensembl (release 41):
medaka (assembly HdrR), green puffer (assembly TETRAODON 7), stickleback (assembly
BROAD S1), fugu (assembly FUGU 4.0), and zebrafish (assembly Zv6). Redundancies were
removed with the WU-BLAST patdb utility, and the reversed sequences added as decoys. The
final database contained 844,832,953 residues in 2,106,626 entries.
Peak lists were generated from the monoisotopic mass spectra filtered with ProteinLynx
Global Server vs. 2.2.5 (Waters) and analyzed with two complementary procedures: Mascot
vs. 2.2.03 (Pappin et al. 1993; Matrix Science, Boston, MA) was used for error-tolerant ion
searches with a peptide mass tolerance of ± 2 Da, a fragment mass tolerance of ± 0.8 Da,
carbamidomethyl-cysteine as fixed modification, and no more than two missed trypsin
cleavages; this procedure matches spectra in a single step directly to database sequences, but
relies on the underlying protein or a close homolog being represented in the database.
Alternatively, PEAKS (Ma et al. 2003; Bioinformatics Solutions, Waterloo, ON) was used to
interpret the peak lists de novo, with peptide and fragment mass tolerances of ± 0.1 Da. The
predicted peptide sequences were then used as queries in MS-BLAST searches (Shevchenko et
al. 2001) with WU-BLAST 2.0 [16-Jun-2004] (Korf et al. 2003; Lopez et al. 2003). This
procedure is less integrated than Mascot, but may be more sensitive for species such as trout and
catfish with fewer known proteins.
To assess the statistical significance of each database match, we calculated an Expect
value, the number of times a match of the same quality was expected to occur by chance in a
database of the same size. For Mascot, Expect values were based on the highest peptide Mowse
score; for PEAKS/MS-BLAST, Expect values were based on a survival curve (Fenyö and Beavis
2003) of the BLAST E-values of the decoy matches. Database matches from the automated
8Mascot and PEAKS/MS-BLAST procedures with at least two matching peptides and Expect
values below 0.05 were analyzed further. Groups of orthologous proteins were reduced to a
single match with the lowest Expect value. Peptides that lacked flanking K or R residues, had
mass errors larger than 0.1 Da, missed more than one internal cleavage, or failed to identify the
same protein on their own in a BLASTP search against the current non-redundant GenBank
database were eliminated, and the search statistics were recalculated.
RT-PCR
First-strand cDNA synthesis from total zebrafish RNA was primed with oligo(dT)18.
Amplifications were cycled 30 times with an annealing temperature of 55°C and contained
cDNA corresponding to 5 to 12.5 ng total RNA per µl and 0.2 µM of each primer (5’ to 3’):
sparc exons 4 and 6, TTGAGGTCGTGGAGGATGTT & GTATTTGCAGGGTCCGATGT;
bactin1 exons 1 and 2, TCTTCACTCCCCTTGTTCAC & GCATCATCTCCAGCAAAACC.
In situ hybridization
The coding region of zebrafish sparc in pBluescript II SK(+) (Stratagene, La Jolla, CA) was
amplified with flanking M13 primers and used as a template to synthesize digoxigenin-labeled
riboprobes with T3 (antisense) or T7 (sense) RNA polymerase. Hybridizations were conducted
as described (Thisse and Thisse 2008). No labeling was detected in control experiments with
sense probe.
Antibody production
The coding sequence for mature zebrafish Sparc was amplified with the primers
GACTCCATGGGCGCTCCAACTGAAGAGGAGCCAGCT and
9GACTCGGCCGCGATGACAAGGTCTTTGTCGACATC and inserted at the NcoI and EagI
sites of the vector pET-28a(+) (Novagen, Madison, WI). The resulting fusion protein with a
C-terminal His6-tag was purified as described (Kollmar et al. 2001) and used to generate
polyclonal antiserum UI-37 in rabbits.
Protein immunoblotting
A crude bone extract from trout was prepared as described (Fisher et al. 1987). Purified bovine
SPARC (osteonectin) was purchased from Haematologic Technologies, Essex Junction, VT.
Total protein from whole zebrafish embryos was isolated with TRIzol reagent (Invitrogen).
Proteins were electrophoresed as above, and blotting and detection were as described (Kollmar et
al. 1997), except that blocking buffer was StartingBlock (Pierce Biotechnology, Rockford, IL)
and detection was based on fluorescence. The primary antibodies were BON-1, a rabbit
polyclonal antiserum against purified bovine SPARC at a dilution of 1:5,000 (Ingram et al.
1993); E7, ascites fluid containing a mouse monoclonal antibody against β-tubulin at 0.2 µg/ml
IgG (Chu and Klymkowsky 1989; Developmental Studies Hybridoma Bank, Iowa City, IA); and
UI-37 (see above) at 1:1,500. The secondary antibodies were donkey anti-rabbit and anti-mouse
IgG antibodies conjugated to IRDye 680 or 800CW (LiCor, Lincoln, NE), respectively, at
67 ng/ml in the presence of 0.01% (wt/vol) sodium dodecylsulfate. Membranes were scanned
with a two-channel Odyssey Infrared Imaging System (LiCor); fluorescence intensity varied
linearly with the amount of protein from 24 to at least 3,000 fluorescence units (r2 = 97%).
Immunofluorescence
Zebrafish embryos were labeled as described (Jowett 1999, protocol 6.12; Starr et al. 2004).
Lapilli from adult zebrafish were cut with a scalpel into slices of 120-300 µm thickness, etched
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for two hours with 17 mM acetic acid, post-fixed for 30 min, and labeled without
permeabilization. Primary reagents were UI-37 or preimmune serum diluted 1:200 or normal
rabbit IgG at 11 µg/ml (Jackson ImmunoResearch Laboratories, West Grove, PA); secondary
reagents were 2.5 µg/ml 4',6-diamidino-2-phenylindole (DAPI) and 2.5 µg/ml Alexa-Fluor-488-
conjugated donkey anti-rabbit IgG or 165 nM Alexa-Fluor-488-conjugated phalloidin (Molecular
Probes). Stacks of fluorescence images were acquired under structured illumination (Apotome;
Carl Zeiss, Thornwood, NY), and maximum-intensity projections in the z-axis prepared with
ImageJ (Wayne Rasband, National Institutes of Health, Bethesda, MD).
Morpholino injections
The morpholinos (5’ to 3’, mismatches in lower case) ATG-MO,
ATCTTGAGTTTCAGCCTTCTGTCCG (Eckfeldt et al. 2005); ATGmis-MO,
ATgTTcAGTTTgAGCCTTgTGTgCG; e5i5-MO, GGAATGAGAAAAGACACGCACATGC;
e5i5mis-MO, GGAATcAGAAAAcACACcCAgATcC; and Std-MO
CCTCTTACCTCAGTTACAATTTATA (Gene Tools, Philomath, OR) were injected as
described (Gilmour et al. 2002). Working dilutions were prepared in vehicle comprising Danieau
buffer, 0.05% (wt/vol) phenol red, and 2.5 mg/ml tetramethylrhodamine dextran 10,000 MW
(Molecular Probes); 1 nl per embryo was injected at the one-cell stage. The order of treatments
was randomized for each experiment. Dead and non-fluorescent embryos were removed after
one day; the fraction of fluorescent embryos among survivors ranged from 33% to 100% with a
median of 86%. At 28, 52, and 76 ± 0.5 hours post fertilization (hpf), a random sample of 12 to
16 embryos was removed from each treatment group for microscopy and subsequent fixation or
RNA and protein isolation.
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Morphant analysis
For otolith measurements, anesthesized embryos were mounted in 3% (wt/vol) methylcellulose
in E2 medium (Kane and Kishimoto 2002), and the otic vesicles were imaged on a compound
microscope. The otolith and otic-vesicle areas were outlined manually with Axiovision 4.6 (Carl
Zeiss). For scanning electron microscopy, otoliths were dissected from embryos fixed with
85% vol/vol ethanol, mounted dry on conductive carbon adhesive tape, and sputter-coated with
gold/palladium. For semi-thin sections, embryos fixed in BT fix (Westerfield 2000) were
embedded in LR White resin hard grade (Electron Microscopy Sciences, Hatfield, PA), sectioned
at 1 µm thickness with a diamond knife on an ultramicrotome, and stained with toluidine blue
(Richardson et al. 1960). Startle responses were examined as described (Kappler et al. 2004).
Analysis of variance and post-hoc Bonferroni comparisons were conducted with Minitab 15
(Minitab, State College, PA).
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Results
Three novel otolith proteins identified by mass spectrometry
To identify unknown otolith proteins in an efficient and comprehensive fashion, we analyzed
crude extracts of trout and catfish otoliths by tandem mass spectrometry in a shotgun approach.
We chose these species because they are farmed commercially and easily available, their otoliths
weigh tens to hundreds of milligrams versus the tens of micrograms in laboratory species such as
the zebrafish, and their complements of otolith proteins appear to be similar to those of a wide
range of actinopterygii (Fig. 1). We chose crude extracts to avoid the losses associated with
separating minute amounts of proteins and because the otolith “proteome” comprises only about
two dozen proteins (Fig. 1). From 10 mg of adult trout or catfish otoliths as starting material, we
extracted about 2 µg each of EDTA-soluble protein under reducing conditions. After digestion
with trypsin and separation of the resulting peptides by liquid chromatography, we obtained 571
mass spectra from trout and 392 from catfish; the smaller number may have been due to the use
of hypochlorite for otolith cleaning and resulted in fewer database matches.
To analyze the spectra, we employed two complementary procedures, Mascot and
PEAKS/MS-BLAST, to search a comprehensive database of chordate proteins. If the top
database match for a group of orthologous proteins was from a different species than the otolith
extract, it was used as a query for post-hoc BLAST searches to find matching trout or catfish
nucleotide sequences. We thus identified three novel otolith proteins with statistically significant
database matches (Table 1).
The first novel otolith protein was Sparc, a Ca2+- and collagen-binding protein and major
constituent of bone and dentin. Its closest paralog, SPARC-like 1, has been found in mouse
otoconia (Thalmann et al. 2006). However, the peptide sequences predicted by PEAKS from
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trout otolith spectra were far more similar to trout Sparc than to trout Sparcl, the ortholog of
mouse SPARC-like 1 (Table 2). Similarly, the PEAKS predictions from catfish were more
similar to zebrafish Sparc than to zebrafish Sparcl (data not shown).
The second was precerebellin-like protein (Cblnl), a member of the family of
C1q-domain-containing proteins that includes collagen types VIII and X and otolin-1. Of the five
tryptic Cblnl peptides matched by Mascot and PEAKS/MS-BLAST, two were more similar to
isoform a and two were more similar to isoform b (Table 3), suggesting that two Cblnl isoforms
are present in otoliths. The underlying nucleotide sequences were about 90% identical; we could
not determine whether the isoforms arose from alternative splicing, polymorphisms, or separate
genes.
The third was neuroserpin (Serpin I1), a member of the large family of serine-protease
inhibitors. Mascot and PEAKS/MS-BLAST identified the zebrafish and the medaka ortholog,
respectively, as the top match. A post-hoc BLAST search identified a set of expressed sequence
tags (ESTs) that encoded trout neuroserpin; their conceptual translation matched the PEAKS
predictions from trout otolith spectra better than any other serpin (data not shown).
In addition, we also observed three of the four known otolith proteins—otolith matrix
protein-1, otolin-1, and otolith matrix macromolecule-64—with one to twelve matching peptides,
5% to 59% coverage, and Expect values between 0.082 and 1.5 · 10–13 (data not shown). The
three novel and three known otolith proteins were the only database matches with significant
Expect values, other than the common contaminants human keratin and porcine trypsin. The
concordance and statistics of the Mascot and PEAKS/MS-BLAST results strongly support the
identification of Sparc, precerebellin-like protein, and neuroserpin as otolith proteins.
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Sparc is a constituent protein of zebrafish otoliths
Sparc was found in both trout and catfish otoliths in our proteomics study (Table 1) and has a
well-established role in bone formation (Brekken and Sage 2000). We, therefore, set out to test
the  hypothesis that Sparc also plays a role in otolith morphogenesis. We started by investigating
its expression in the zebrafish, an animal model that is more tractable for embryological and
genetic studies than trout or catfish.
The level of sparc mRNA was seen to step up around 9 hpf, near the end of gastrulation,
in a qualitative RT-PCR assay with whole zebrafish embryos (Fig. 2A). At 14 hpf, sparc mRNA
was located in the otic placode of zebrafish embryos by in situ hybridization; the signal was
stronger than anywhere else, including somites and floorplate (see Fig. 2B and data not shown;
for the anatomy of the developing zebrafish ear, see Haddon and Lewis 1996; Whitfield et al.
2002). Within the otic vesicle at 28 hpf, the mRNA became more regionalized (Fig. 2C); at
52 hpf, it was concentrated in one domain marking the sensory maculae and in another marking
the developing semicicular canals (Fig. 2D). At least until 7 dpf, the mRNA level in the ear
remained comparable to that in other areas of the body, such as the notochord (data not shown;
see also Thisse B, Thisse C. Fast release clones: a high throughput expression analysis. ZFIN
Direct Data Submission, http://zfin.org, 2004; Rotllant et al. 2008). The expression of the sparc
gene in the ear thus commences long before the seeding period of otolith formation begins
around 18 hpf.
To verify the presence of Sparc in otoliths, we first conducted protein immunoblotting
experiments. In a crude extract of zebrafish otoliths, a single protein was detected by antiserum
UI-37 raised against recombinant zebrafish Sparc in our laboratory (Fig. 2E). The protein’s
mobility corresponded to the apparent molecular mass of 39 kDa typical for reduced Sparc (Sage
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2003) and matched that of a band of intermediate intensity in a silver-stained gel slice (Fig. 2E).
Control experiments demonstrated that the UI-37 serum bound to Sparc in a specific manner:
Binding was impervious to preadsorption of the serum with a plain bacterial extract, but was
blocked by preadsorption with a bacterial extract containing recombinant zebrafish Sparc; no
signal was observed with preimmune serum, with purified naive rabbit IgG, or without primary
antibody (Fig. 2E). Furthermore, both UI-37 and BON-1, an antiserum against bovine SPARC,
detected a single protein of the same mobility in extracts from trout otoliths and bone and bound
to purified bovine SPARC (data not shown).
Next, we located Sparc in the ears of zebrafish embryos by whole-mount
immunofluorescence labeling. At 28 hpf, antiserum UI-37 detected Sparc at the surface of both
otoliths and throughout the epithelium that lines the otic vesicle (Fig. 2F); the latter signal was
strongest at the caudal end, matching the distribution of the sparc mRNA (Fig. 2C). The
specificity of Sparc recognition by UI-37 was demonstrated by using the same controls as for
immunoblotting above (Fig. 2G and data not shown). This result demonstrated that Sparc is
incorporated into otoliths already at the earliest stage of their life-long growth phase.
Finally, to demonstrate that the Sparc detected above was not an accidental contaminant
from adhering tissue or extracellular matrix, we examined cross-sections of adult zebrafish
otoliths by immunofluorescence microscopy. Fluorescent labeling was observed with UI-37
serum (Fig. 2H-I). The same control experiments as for immunoblotting above demonstrated the
specificity of the labeling (Fig. 2J-K, L-M, and data not shown). Together, these expression
studies confirmed and extended our proteomics results and demonstrated that Sparc is a true
constituent of otoliths.
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Diminished Sparc expression in zebrafish morphants
To manipulate the level of Sparc expression, we turned to injecting antisense morpholino
oligonucleotides (“morpholinos”) into zebrafish embryos (“morphants”). The first morpholino
was designed to block translation by binding to the 5’-UTR and start codon of the sparc mRNA
(Fig. 3A, ATG-MO). The second morpholino was designed to block splicing by binding to the
donor site at the junction of exon 5 and intron 5 (Fig. 3A, e5i5-MO). Morpholinos with five
nucleotide mismatches (ATGmis-MO, e5i5mis-MO) or directed against a mutant human
β-globin mRNA (Std-MO) were used as negative controls. To find optimal concentrations, we
titrated the morpholinos over a range of 0.46-4.5 ng per embryo. ATG-MO and e5ie-MO doses
above 1 ng induced the otolith abnormalities described below in a reproducible and dose-
dependent manner (data not shown). Above 4 ng, however, most embryos died by three days of
age. We, therefore, chose 2.0 and 2.4 ng per embryo as the optimal doses for ATG-MO and
e5i5-MO, respectively.
 To verify that the morpholinos targeted Sparc, we measured their effect on mRNA and
protein levels. After injection of 2.4 ng e5i5-MO per embryo, RT-PCR with flanking primers in
exons 4 and 6 detected multiple splice isoforms at 28, 52, and 76 hpf in two independent
experiments (Fig. 3B and data not shown). We were able to sequence four isoforms: The first
originated from a cryptic splice donor site inside exon 5 (a in Figs. 3A-B), the second from the
normal donor site at the exon-intron junction (b), the third from a cryptic donor site inside
intron 5 (c), and the fourth retained all of intron 5 (unspliced). The deletion in isoform a and the
insertion in c were in-frame, encoding peptides with 26 additional or 12 missing amino acids,
respectively. The most abundant, unspliced isoform encoded a foreshortened 112-amino-acid
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peptide because of a premature stop codon in intron 5. In contrast, only the wild-type isoform b
was detected after injecting negative controls (Fig. 3B).
A major reduction of Sparc protein after injecting 2.0 ng ATG-MO or 2.4 ng e5i5-MO
per embryo was revealed by two-color immunofluorescence blotting with the UI-37 antiserum
and a mouse monoclonal antibody against β-tubulin (Figs. 3C-D). Based on quantitation within
the linear range of the fluorescence signal, the Sparc content in ATG- and e5i5-morphants at 28
to 76 hpf was reduced between 7- and 44-fold when compared to controls of the same age
(Fig. 3D). In contrast, the β-tubulin content varied at most by a factor of 2.4 among samples of
the same age (Fig. 3C and data not shown). In ATGmis-MO and e5i5mis-MO controls, the Sparc
content was also reduced when compared to vehicle- and Std-MO controls, but no more than
two-fold; these small effects may have been due to the finite affinities of the mismatch
morpholinos. The abnormal Sparc peptides predicted from the misspliced mRNAs in the
e5i5-morphant were not observed, suggesting that they were unstable. Together, the RT-PCR
and immunoblotting results indicated a substantial and specific reduction of Sparc levels in
ATG- and e5i5-morphants.
Sparc is required for normal otolith growth
To assess the functional requirement for Sparc in otolith formation, we analyzed otolith
morphology at 28, 52, and 76 hpf for ATG- and e5i5-morphants in three independent
experiments each. In wild-type otic vesicles observed live under brightfield illumination, a pair
of spheroidal otoliths is visible at each age in stereotypic locations, the anterior lapillus and the
posterior sagitta (Fig. 4A). In both ATG- and e5i5-morphants, we consistently observed
abnormalities regarding four attributes (Fig. 4B-D): size (smaller otoliths), shape (fused otoliths),
location (ectopic otoliths), and number (missing or up to three extra otoliths). Fused otoliths were
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sometimes difficult to distinguish and therefore not tallied separately. However, dissection and
scanning electron microscopy confirmed that fused and smaller otoliths were not artifacts of the
fixed perspective under the light microscope (Fig. 4E-I). Ectopic otoliths were usually located
close to the anterior or posterior macula and appeared to be attached. Sectioning revealed a
striking difference between wild-type and morphant otoliths: In the former, a small, dark core
was surrounded first by thick, light layers of striated, mineralized matrix and then by a thin, dark,
unmineralized rim with a distinct margin (Fig. 4J). In the latter, the core, mineralized matrix, and
rim were much smaller and occasionally enclosed by an additional, proteinaceous layer.
Furthermore, the entire assembly stained more darkly, suggesting a higher ratio of protein to
CaCO3 in morphant otoliths (Fig. 4K).
Smaller size was by far the predominant phenotype and occurred often alone. To quantify
its prevalence, the total otolith area visible under brightfield illumination was measured
(Fig. 4L). The mean of the total otolith area in both morphants, as determined by analysis of
variance, was about half that of vehicle- or Std-MO-injected controls. These differences were
highly significant and mirrored the diminished Sparc expression reported above (Fig. 3D). In
ATGmis- and e5i5mis-morphants, the mean was also reduced, but the effect was far less
pronounced. Furthermore, individual otoliths in morphants were never abnormally large. In
particular, ectopic otoliths were usually smaller than the lapillus and sagitta in the same otic
vesicle, and even fused otoliths were rarely larger than the mean in controls of the same age.
These results suggested a requirement for Sparc in otolith growth.
The other abnormalities frequently occurred in combination, such as an extra, ectopic
otolith (Fig. 4C) or a missing otolith fused to another (Fig. 4D). To quantify their prevalence,
embryos were classified according to the presence or absence of lapillus and sagitta; each group
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was then subdivided according to the absence or presence of ectopic otoliths (Table 4). The
proportion of each phenotype was similar in the two morphant types. Almost all morphants
retained both a lapillus and a sagitta in its normal location. Extra otoliths were more common
than partially or completely missing otoliths. The probabilities of loosing either the lapillus or
the sagitta were almost equal (4% vs. 3% when averaged over all ages). The percentage of
abnormal otolith numbers decreased with age, regardless of treatment.
Sparc plays a direct role in otolith growth
Consistent with the widespread expression of Sparc, we observed abnormalities elsewhere in the
ATG- and e5i5-morphants, such as defective otic vesicles and twisted fins. The survival after one
week of the morphants, but not of the mismatch- or Std-MO-injected controls, was significantly
lower than that of the vehicle-injected controls (37%±6% vs. 67%±5%, mean ± SEM, P = 0.01
with 17 df). Similarly, the fractions of spontaneously (31%±6%) or upright (62%±5%)
swimming morphant larvae at one week of age were significantly lower than those of the
vehicle-injected controls (70%±9% and 95%±3%, P = 0.02 and 0.001, respectively, with 17 df),
whereas the fractions exhibiting a startle response to sound were indistinguishable (96%±2% vs.
100%±3%); these differences may have been due to the fin defects or to vestibular dysfunction.
The otic-vesicle abnormalities in morphants included smaller size and disrupted
semicircular canals, but did not extend to features associated with otoliths, such as the
morphology of the anterior macula (Fig. 4J-K) or its number of hair bundles (Fig. 4M-N).
Furthermore, whereas the otolith defects were equally severe in the ATG- and e5i5-morphants
(see above), the otic-vesicle defects were much milder in the latter. While the epithelial
projections forming the semicircular canals at later stages (52 and 76 hpf) were less prominent in
e5i5-morphants than in vehicle- or Std-MO-injected controls, the overall appearance of the otic
20
vesicle was often indistinguishable (see Fig. 4A vs. B-D); the exception were otic vesicles
without any otoliths, which were always tiny and looked grossly abnormal. This impression was
confirmed quantitatively by analysis of variance of the visible otic-vesicle area as a proxy for
size: ATG-morphants, but not e5i5-morphants, had significantly smaller vesicles than control
embryos (Table 5). These observations were consistent with the higher residual Sparc levels in
e5i5- than in ATG-morphants (Fig. 3D).
To assess whether Sparc knockdown affected otolith growth directly or indirectly, via
defects in otic-vesicle development, we focussed on the predominant phenotype, smaller otoliths,
in isolation. Plotting otolith size against otic-vesicle size for embryos with only a properly-
located lapillus and sagitta revealed a weak linear correlation in vehicle- and Std-MO-injected
embryos at 52 and 76 hpf (Fig. 4O and data not shown). ATG- and e5i5-morphants also
displayed linear correlations, but with much smaller intercepts. At any given otic-vesicle size, the
mean otolith size was thus always substantially smaller in morphants than in controls. Together,
these observations demonstrated that otolith growth in Sparc morphants is reduced regardless of
the severity of otic-vesicle defects and suggested that Sparc plays a direct role in otolith growth.
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Discussion
Our mass-spectrometry analysis revealed the presence of Sparc, precerebellin-like protein, and
neuroserpin in trout and catfish otoliths. None of these proteins had been associated previously
with otolith or otoconia formation. Immunodetection confirmed independently that Sparc is a
true constituent of trout and zebrafish otoliths. Finally, knockdown of Sparc expression in
morphant zebrafish resulted in four principal types of defective otoliths: smaller, extra and
ectopic, missing and fused, or completely absent. Smaller size was the predominant phenotype
and independent of the severity of otic-vesicle defects. These results suggested that Sparc is
directly required for normal otolith growth.
By taking a shotgun proteomics approach, we almost doubled the number of known
otolith proteins. Previously, constituent otolith proteins had been isolated one at a time by
electrophoresis (Murayama et al. 2000; Murayama et al. 2002), database searches (Söllner et al.
2003; Petko et al. 2008), or immunoscreening (Tohse et al. 2008). Recently, Zhao and colleagues
(2007) employed mass spectrometry to detect three proteins in a crude extract from mouse
otoconia: otoconin 90 (Wang et al. 1998; Verpy et al. 1999) and fetuin-A (Thalmann et al. 2006)
as well as otolin-1, whose ortholog had previously been isolated from salmon otoliths
(Murayama et al. 2000). We identified three new and three out of four known otolith proteins
concurrently by taking advantage of a rich source—the large otoliths of commercially farmed
species—and the recent advances in proteomics technology (Domon and Aebersold 2006). This
strategy may be useful in general for studying tissues or organs that are too small in laboratory
species, such as the zebrafish, to yield sufficient material. Even with seven known constituents,
though, the catalog of otolith proteins is unlikely to be complete yet. Further advances may
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require additional sample treatments, such as deglycosylation or harsher fragmentation,
especially for the insoluble fraction, before mass spectrometry.
Sparc, the first otolith protein we identified, is a multifaceted molecule with a broad
range of physiological effects. It occurs in most basement membranes, dentin, cartilage, and
bone of vertebrates, where it constitutes up to 23% of total protein by weight (Termine et al.
1981; Brekken and Sage 2000). It belongs to the matricellular proteins that modulate the
assembly and maintenance of the extracellular matrix, but do not provide structural support
(Bradshaw and Sage 2001). Rotllant and colleagues (2008) have recently shown that Sparc is
required for the morphogenesis of pharyngeal cartilage and for later stages of inner-ear
development in zebrafish, but do not report on otolith abnormalities in their morphants. Sparc
knockout mice exhibit, among other defects, curly tails and a weaker skin (Bradshaw et al.
2003), a reduced foreign-body reaction (Puolakkainen et al. 2003), accelerated vertebral disc
degeneration (Gruber et al. 2005), and reduced bone mass and strength (osteopenia) despite
normal development of the skeleton overall (Gilmour et al. 1998; Delany et al. 2000; Boskey et
al. 2003); in each case, the associated molecular abnormalities include an altered collagen
ultrastructure. Sparc acts on the extracellular matrix both directly and indirectly: A C-terminal
extracellular Ca2+-binding module also binds to collagen and may provide a chaperone or escort
function during secretion and assembly, and an internal follistatin-like module influences the
proliferation, differentiation, and adhesion of surrounding cells (Bradshaw and Sage 2001;
Martinek et al. 2007; Rentz et al. 2007). Because of the affinity of its N-terminal acidic module
for both Ca2+ and hydroxyapatite, Sparc may also act as a linker between collagen and the
mineral phase in bone and promote mineralization. In vitro, however, Sparc has been variously
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found to stimulate (Termine et al. 1981), inhibit (Romberg et al. 1986; Doi et al. 1989), or not at
all affect (Hunter et al. 1996) hydroxyapatite formation, leaving this hypothesis unresolved.
Sparc belongs to a group of homologous proteins with important roles in tissue
mineralization. Its closest paralog Sparc-like (Sparcl) gave rise, via gene duplications, to the
secreted calcium-binding phosphoproteins (Kawasaki and Weiss 2006) that include the otolith or
otoconia proteins starmaker (Söllner et al. 2003), otolith matrix macromolecule-64 (Tohse et al.
2008), and osteopontin (Sakagami 2000; Thalmann et al. 2006; Zhao et al. 2008). Sparc-like
itself, which is about twice the size of and 50-70% identical to Sparc, has been found in mouse
otoconia (Thalmann et al. 2006. We cannot exclude the possibility that Sparc-like is also present
in otoliths; however, we did not detect sparcl mRNA in the developing zebrafish ear by in situ
hybridization (Y.-J.K., A.S., & R.K., unpublished). In contrast, we and others have observed a
strong and specific signal for sparc mRNA in the ear of zebrafish and medaka embryos (Thisse
and Thisse 2004; Renn et al. 2006; Nemoto et al. 2008; Rotllant et al. 2008). Furthermore, the
sequence alignments of our mass-spectra predictions and our immunodetection experiments
clearly identified Sparc as a constituent of otoliths. The secreted calcium-binding
phosphoproteins appear to have diverged and exchanged roles throughout the vertebrate lineage
(Kawasaki and Weiss 2006). In a similar fashion, Sparc and Sparc-like may perform the same
role in otoliths and otoconia, respectively.
The otolith abnormalities in our Sparc morphants encompassed all the main phenotypes
of otoconin 90 (smaller, extra, or missing; Petko et al. 2008), otolith matrix protein (smaller;
Murayama et al. 2005), and otolin-1 (fused; Murayama et al. 2005), but appeared to be opposite
to that of starmaker (reduced vs. enhanced mineralization; Söllner et al. 2003). This would be
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consistent with, but not proof of genetic or physical interactions between Sparc and some or all
of these otolith proteins.
Sparc’s multifaceted nature and widespread expression raise the question whether the
otolith abnormalities in the morphants were a non-specific consequence of earlier defects
elsewhere in the body. Based on the expression patterns of molecular markers, knockdown of
Sparc expression in zebrafish morphants does not perturb early ear development, until 24 hpf,
and later defects are not due to general retardation (Rotllant et al. 2008). This conclusion should
extend to otolith growth, which occurs late in ear development. Furthermore, our morpholino
doses were lower than those of Rotllant and colleagues (0.2-0.3 vs. 0.5-1 pmol per embryo), and
the survival rate of our morphants at 7 dpf was higher (36% vs. <20%); non-specific effects in
our morphants should thus be even less pronounced than in their study.
Consideration of the critical seeding period of otolith formation between 18.5 hpf and
24 hpf (Riley et al. 1997) further supports a later time frame for the effects of Sparc knockdown.
During this seeding period, diffusible seeding particles must attach to tether cells in the anterior
and posterior macula to initiate the subsequent life-long growth period of a properly-located
lapillus and sagitta, respectively. Tethering defects characteristically lead to the formation of a
single, oversized otolith, with a preferential loss of the lapillus over the sagitta (Riley et al. 1997;
Riley and Moorman 2000; Sumanas et al. 2003). In contrast, we observed both a lapillus and a
sagitta in their proper locations in 80%-96% of our Sparc morphants. In the small fraction of
animals with a single otolith, lapillus and sagitta were lost with almost equal probability. Lack of
seeding or tethering is, therefore, unlikely to underlie the majority of abnormal otoliths in Sparc
morphants.
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To distinguish between direct and indirect effects of Sparc knockdown, we focused on
the smaller-size phenotype, which predominated and often occurred alone, and the period of
otolith growth after 24 hpf. Two lines of evidence argue against an indirect consequence of otic-
vesicle defects. First, our demonstration that Sparc protein is a true constituent of otoliths
suggested a direct role in their morphogenesis. It seems unlikely that the incorporation of Sparc
at all ages from embryo to adult is purely adventitious. Second, the comparison of our ATG- and
e5i5-morphants suggested that otolith size and otic-vesicle phenotype were independent. Rotllant
and colleagues (2008) reported three characteristic and specific anatomical defects of otic-
vesicles in Sparc morphants at 68 hpf: a markedly smaller ear, closer apposition of the anterior
and posterior macula, and disrupted formation of the semicircular canals. In our observations at
52 and 76 hpf, we detected a much milder otic-vesicle phenotype in the e5i5-morphants—no
significant difference in otic-vesicle size from control embryos and no displacement of the
maculae, as judged from the locations of lapillus and sagitta. Only the semicircular canals were
abnormal, which form a separate domain of Sparc expression from the maculae and are not
thought to be involved in otolith formation. Otolith size, in contrast, was reduced just as
significantly in the e5i5-morphants as in the ATG-morphants with a more severe otic-vesicle
phenotype. While it is fundamentally impossible to rule out all other explanations, our results
indicate a requirement for Sparc in otolith growth that is specific, direct, and independent from
its role in otic-vesicle development. At the molecular level, morphant otoliths may be smaller
and their mineral phase reduced because the collagenous otolin-1 or other structural proteins are
not properly assembled into a framework in the absence of Sparc; alternatively, the CaCO3 may
not be properly deposited on or linked to the framework without Sparc.
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Because the other otolith abnormalities in Sparc morphants occurred less frequent and in
numerous combinations, we can interpret them only tentatively. Extra, ectopic otoliths, the
second-most common phenotype, may have resulted from a reduction in the stickiness that
allows seeding particles to fuse with a tethered lapillus or sagitta (Riley et al. 1997) and that may
also underlie the decreasing frequency of extra otoliths with age in both morphants and controls.
This stickiness could depend on Sparc’s direct participation in framework assembly or
mineralization at the otolith surface. The rare opposite phenotype of missing single otoliths, in
contrast, likely arose from Sparc’s role in otic-vesicle development. Its frequent coincidence with
fused otoliths suggests a closer apposition of the anterior and posterior macula or impaired
tethering as the underlying cause. Finally, the tiny and grossly abnormal otic vesicles
accompanying the occasional lack of any otoliths make it impossible to distinguish between
non-specific, indirect, and direct effects for this phenotype. We conclude that only a small
fraction of the abnormal otoliths in morphants should be attributed to indirect rather than direct
effects of Sparc knockdown.
Precerebellin-like (Cblnl), the second new otolith protein we identified, may partner with
Otolin-1 during framework assembly. Trout Cblnl contains a secretory signal peptide and a
globular C1q domain; its structure thus resembles those of collagens VIII and X and of Otolin-1,
except that it lacks their collagen-like region (Gerwick et al. 2000; Tom Tang et al. 2005; Mei
and Gui 2008). The short-chain collagens VIII and X assemble into a reticular network with hubs
formed by trimers of C1q domains and spokes formed by collagen fibrils (Kwan et al. 1991;
Sutmuller et al. 1997). The insoluble protein fraction of otoliths also forms a reticular network
(Zhang 1992). Cblnl could thus be associating with Otolin-1 via their C1q domains and reduce
the connectivity of the internal hubs or cap the hubs at surfaces.
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Neuroserpin (SerpinI1), the third new otolith protein we identified, may also be involved
in framework assembly. It is a secreted member of the large family of serine-protease inhibitors
and a modulator of proteolytic cascades (Miranda and Lomas 2006). One of its key substrates is
tissue plasminogen activator, a serine protease that converts other proteases into their active
form, such as the eponymous plasminogen into plasmin. In bone, plasmin activates matrix
metalloproteases with collagenase activity during various stages of development or resorption
(Varghese 2006). For example, the conversion of cartilage to bone (endochondral ossification)
involves the proteolysis of collagen X, a close paralog of otolin-1, and its replacement by
calcium phosphate (Ballock and O'Keefe 2003; Shen 2005). Intriguingly, Sparc anchors tissue
plasminogen activator to collagen and enhances local plasmin activity (Kelm et al. 1994).
Neuroserpin and Sparc could thus be localizing and regulating protease activity together during
otolith formation.
In summary, we have identified three new otolith proteins that may interact with the
collagenous otolin-1 during framework assembly and mineralization. Future studies to test this
hypothesis will need to examine the location and function of precerebellin-like protein and
neuroserpin as we did for Sparc, the ultrastructure of the extracellular matrix, and the dynamic
associations among these three proteins and Otolin-1 in wild-type and morphant zebrafish.
Because of their acellular structure, otoliths could complement the more complicated bone and
tooth as a model system for dissecting Sparc’s roles in biomineralization.
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Figure Legends
Fig. 1. Similarity and moderate complexity of protein complements in actinopterygian otoliths.
(A) Otolith proteins of commercial and laboratory freshwater fishes separated by gel
electrophoresis and stained with silver. Aliquots corresponding to about 1.2 mg otoliths per lane;
apparent molecular masses in kDa indicated on the left. (B) Phylogeny of fish species mentioned
in this study: White sturgeon (Acipenser transmontanus), zebrafish (Danio rerio), bighead carp
(Aristichthys nobilis), channel catfish (Ictalurus punctatus), black ghost (Apteronotus albifrons),
rainbow trout (Oncorhynchus mykiss), chum salmon (Oncorhynchus mykiss), tilapia
(Oreochromis sp.), japanese medaka (Oryzias latipes), torafugu (Takifugu rubripes), spotted
green pufferfish (Tetraodon nigroviridis), and three-spined stickleback (Gasterosteus aculeatus).
Dotted lines in the cladogram indicate five or six actinopterygian clades each that were not
represented.  At three branch points, the estimated time since the last common ancestor is shown
(Kumar and Hedges 1998; Wittbrodt et al. 2002).
Fig. 2. Localization of zebrafish Sparc mRNA in the ear and protein in otoliths. (A) The mRNAs
of sparc and β-actin detected in whole embryos during early development by RT-PCR. (B-D)
The mRNA of sparc detected in the developing ear by in situ hybridization. Dorsal views of
hindbrain area, anterior at the top; outline in B, left otic placode; arrowheads in D, posterior
maculae along the medial wall of the otic vesicle; arrows in D, semicircular canals; scale bar in B
for all three panels, 50 µm. (E) Sparc protein detected in an adult-otolith extract by
immunoblotting. About 0.6 µg total protein per membrane strip; Silver, silver-stained gel slice;
Sparc, anti-Sparc serum UI-37; E. coli-adsorbed, UI-37 pre-adsorbed with a plain bacterial
extract;  Sparc-adsorbed, UI-37 pre-adsorbed with a bacterial extract containing recombinant
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zebrafish Sparc; dashes on the right, molecular-mass markers (kDa, from top): 250, 160, 105, 75,
50, 35, 30, 25, 15, 10. (F) Sparc protein detected in otic vesicles by whole-mount
immunofluorescence. Green, Sparc labeled with antiserum UI-37; blue, nuclei labeled with
DAPI; arrowheads, lapillus (left) and sagitta (right); lateral view of otic vesicle, dorsal at the top,
anterior to the left; projections of 10-µm stacks of optical sections; scale bar for panels F and G,
25 µm. (G) Same as F, but with purified naive rabbit IgG instead of UI-37. (H-I) Sparc protein
detected in a transverse section of an adult lapillus. H, brightfield view of an  otolith slice; I,
immunofluorescence with antiserum UI-37 at the surface of the slice’s cross-section; scale bar in
H for panels H to M, 100 µm. (J-K) Same as H-I, but UI-37 pre-adsorbed with a plain bacterial
extract. (L-M) Same as H-I, but UI-37 pre-adsorbed with a bacterial extract containing
recombinant zebrafish Sparc. Because the brightfield images in H, J, and L were overexposed to
visualize the growth rings, the visible otolith margins do not exactly match the fluorescent areas;
I, K, and M are projections of 58 to 87-µm-thick stacks of optical sections that were acquired
under matched settings.
Fig. 3. Diminished Sparc expression in morphant zebrafish embryos. (A) Schematic of the
ATG-MO morpholino binding to the start codon of sparc mRNA and the e5i5-MO morpholino
binding to the junction of exon 5 and intron 5. GTa–c, splice donor sites; AG, splice acceptor site;
For and Rev, PCR primers used in B. (B) Misspliced sparc mRNAs in e5i5-MO morphants at
28 hpf detected by RT-PCR. Injected reagents at the top; size markers in bp on the left; products
derived from splicing at donor sites GTa–c or the unspliced pre-mRNA indicated on the right. (C)
Example of protein detection in microinjected embryos at 52 hpf by two-color
immunofluorescence blotting with antibodies against Sparc (red) and β-tubulin (green). Total
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protein pooled from ten embryos each; equivalent of one embryo loaded per lane. (D) Summary
of Sparc levels measured by immunofluorescence blotting. One set of injections each for
ATG-MO and e5i5-MO; mean and range indicated by error bar for vehicle and Std-MO controls.
Fig. 4. Otolith abnormalities in zebrafish Sparc morphants. (A-D) Phenotypes of otoliths in
microinjected embryos under brightfield illumination. Lateral views of otic vesicles, dorsal at the
top, anterior to the left; arrowheads, lapillus (left) and sagitta (right) in A and extra/ectopic
otolith in C; scale bar for all four panels in A, 30 µm; some ototliths were imaged in a slightly
different focal plane. (E-I) Scanning electron micrographs of dissected otoliths from injected
embryos. Scale bar for all five panels in E, 10 µm. (J-K) Structure of wild-type and morphant
otoliths visualized by staining with toluidine blue. Coronal semi-thin sections of anterior
maculae and lapilli; scale bar for both panels in K, 10 µm. (L) Summary of otolith areas
measured in bright field images. Two-way ANOVA of three independent experiments for each
morpholino; N = 94-107 per age and treatment for vehicle and Std-MO, 49-57 otherwise; error
bars, 95% confidence intervals; *, significantly different in Bonferroni post-hoc pairwise
comparisons from all other groups of the same age at P ≤ 10–4 and 403-418 df. (M-N) Hair
bundles in wild-type and morphant anterior maculae visualized by labeling with fluorescent
phalloidin. Dorsal views; projections of 17-µm stacks of optical sections; scale bar for both
panels in N, 10 µm; 27 bundles in M, 26 in N. (O) Smaller otoliths in morphants regardless of
otic-vesicle size. Only ears with both lapillus and sagitta, but no extra otoliths; r2 of least-
squares-fitted lines was 22%, 36%, and 39%, respectively, for Vehicle, ATG-MO, and e5i5-MO.
TABLE 1
Three proteins identified newly in otoliths by mass spectrometrya
Top Database Match Mascot Statistics PEAKS/MS-BLAST Statistics
__________________________________________________________ _________________________________ ___________________________________Otolith




Covg Expectb Nr of
Peps
Covg Expectc
Secreted Protein, Acidic, Cysteine-Rich (Sparc)
Trout Trout AAC99813.1 300 4 19% 1.8 · 10-9 5 22% 7.3 · 10-4
Catfish Zebrafish NP_001001942.1 291 2 11% 3.2 · 10-6 5 23% 2.0 · 10-3
      ” Catfishd ESTs CF262751.1 &
CV987488.1
291 nd nd nd 5 23% 1.2 · 10-4
Precerebellin-Like Protein (Cblnl)
Trout Trout AAF04305.2 (isoform a) 182 4 34% 2.5 · 10-7 4 32% 1.3 · 10-2
    ”     ”   d ESTs CX140456.1 &
CX140457.1 (isoform b)
206 nd nd nd 5 36% 4.3 · 10-4
Neuroserpin (SerpinI1)
Trout Zebrafish XP_685811.1 448 3 9% 7.4 · 10-4 – – –
    ” Medaka ENSORLP00000015491e 401 – – – 8 37% 8.3 · 10-4
    ” Troutd ESTs CA373728.1,
CX251911.1, & CX251912.1
~416 nd nd nd 9 37% 6.9 · 10-8
a aa, amino acids; Pep, peptide; Covg, coverage; nd, not determined
b Based on the highest peptide MOWSE score
c Based on the protein BLAST E-value
d Identified in post-hoc BLAST search
e In Ensembl genome assembly HdrR
TABLE 2
Sparc, but not Sparcl identified in trout otoliths
Nr Origina Peptideb
1 PEAKS   LHLDYLGPCK
Sparc K.LHLDYIGPCK.F
Sparcl R.LHLDYTGPCK.F
2 PEAKS   FLEACMDAELNEFPLR
Sparc K.FIEACMDAELNEFPLR.M
Sparcl K.FIAPCMNGELVQFPLR.M
3 PEAKS   NVLVSLYER
Sparc K.NVLVTLYER.D
Sparcl K.NVLLQLYEH.D
4 PEAKS   LQAGEHSLDLLAHDFEK
Sparc R.LQAGEHSLDLLAHDFEK.N
Sparcl R.LHAGDHPIELLAQDFEK.D
5 PEAKS   LYALEEWANCFSLK
Sparc K.YIALEEWANCFSIK.E
Sparcl [EST too short at 3’ end]
aPEAKS, prediction from mass spectrum; bold, mass
error <0.03; Sparcl accession, BX909167.3.
bMismatches with PEAKS shaded (I & L treated as
identical); flanking residues separated by ‘.’.
TABLE 3
Two Cblnl isoforms identified in trout otolithsa
Nr Origin Peptideb
1 PEAKS   ESEVDGLLR
Cblnl-a T-ESEVDGLLR.E
Cblnl-b T-ESEVDGLLR.E
2 PEAKS   VSDEHYHLGPFDK
Cblnl-a M.INDEHYHLGPFGE.N
Cblnl-b R.VSDEHYHLGPFDK.Y
3 PEAKS   VLTNLGEAYNPDTGVFTAPVR
Cblnl-a K.VITNIGEAYNPDTGVFTAPVR.G
Cblnl-b K.VTTNIGEAYNPDTGVFTAPVR.G
4 PEAKS   SGLYHE-VAGVTLDLVK
Cblnl-a K.SGIYHGGANGVTLDLVK.G
Cblnl-b K.SGVYHSGANGVTLDLVE.G
5 PEAKS   LSMFSGYLLFPLDNK
Cblnl-a R.INMFSGYLLFPITTK.*
Cblnl-b R.ISMFSGYLLFPIDNK.*
aKey, see Table 2; Cblnl accessions, see Table 1.
b–, signal-peptide cleavage site; *, C-terminus.
TABLE 4




Lap. & Sag. Lap. Sag. Neither
28 hpf
Vehicle 97 / 3  – / – – / – – / –
Std-MO 88 / 11 – / – – / – 1 / –
ATG-MO 56 / 29 – / 2 4 / – 9 / –
ATGmis-MO 85 / 15 – / – – / – – / –
e5i5-MO 53 / 27 2 / – – / – 18 / –  
e5i5mis-MO 78 / 20 – / – – / – 2 / –
52 hpf
Vehicle 100 / –    – / – – / – – / –
Std-MO 100 / –    – / – – / – – / –
ATG-MO 76 / 13 4 / – 4 / – 4 / –
ATGmis-MO 100 / –    – / – – / – – / –
e5i5-MO 50 / 46 4 / – – / – – / –
e5i5mis-MO 94 / 6  – / – – / – – / –
76 hpf
Vehicle 99 / 1  – / – – / – – / –
Std-MO 99 / –  – / – – / – 1 / –
ATG-MO 72  / 12 2 / – 9 / 2 2 / 2
ATGmis-MO 100 / –    – / – – / – – / –
e5i5-MO 68 / 21 2 / 2 5 / – 2 / –
e5i5mis-MO 100 / –    – / – – / – – / –
aWithout any extra otoliths / with 1-3 extra otoliths; e.g.,
first row, first column: 97% with lapillus (Lap.) and
sagitta (Sag.) alone / 3% with lapillus and sagitta plus
extra otoliths; N = 94-107 per age for Vehicle & Std-MO,
49-57 otherwise.
TABLE 5
Milder otic-vesicle phenotype in e5i5-morphants
Treatment Otic-vesicle area (103 · µm2)a
52 hpf
Vehicle 8.17 ±  0.14 (100)
Std-MO 8.16 ±  0.13 (102)
ATG-MO 5.92 ±  0.18 (55) **
ATGmis-MO 7.29 ±  0.19 (52) *
e5i5-MO 8.26 ±  0.19 (51)
e5i5mis-MO 8.26 ±  0.19 (53)
76 hpf
Vehicle 14.72 ± 0.30 (94)
Std-MO 14.52 ± 0.28 (107)
ATG-MO 11.40 ± 0.31 (55) **
ATGmis-MO 13.15 ± 0.35 (55) *
e5i5-MO 14.93 ± 0.40 (55)
e5i5mis-MO 13.90 ± 0.39 (49)
aMean ± SEM (n)
*Significantly different from ‘Vehicle’ (P ≤ 0.01)
**Significantly different from ‘Vehicle’ (P < 10–4)




